Literature DB >> 19368502

Decrease in serial prevalence of coinfection with hepatitis C virus among HIV-infected patients in Spain, 1997-2006.

Santiago Pérez Cachafeiro1, Julia Del Amo, Jose A Iribarren, Miguel Salavert Lleti, Félix Gutiérrez, Ana Moreno, Pablo Labarga, Juan A Pineda, Francesc Vidal, Juan Berenguer, Santiago Moreno.   

Abstract

The prevalence of injection drug use decreased from 67.3% in 1997 to 14.5% in 2006 among Spanish patients infected with human immunodeficiency virus (HIV). A parallel decrease in the prevalence of coinfection with hepatitis C virus was observed, from 73.8% in 1997 to 19.8% in 2006. This steady decrease in the prevalence of coinfection among Spanish patients was caused by a change in transmission routes of HIV infection.

Entities:  

Mesh：

Year:  2009        PMID： 19368502     DOI： 10.1086/598333

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  12 in total

1.  Broad phenotypic cross-resistance to elvitegravir in HIV-infected patients failing on raltegravir-containing regimens.

Authors:  Carolina Garrido; Jorge Villacian; Natalia Zahonero; Theresa Pattery; Federico Garcia; Felix Gutierrez; Estrella Caballero; Margriet Van Houtte; Vincent Soriano; Carmen de Mendoza
Journal:  Antimicrob Agents Chemother       Date:  2012-03-26       Impact factor: 5.191

2.  Incidence of multiple Herpesvirus infection in HIV seropositive patients, a big concern for Eastern Indian scenario.

Authors:  Nilanjan Chakraborty; Sohinee Bhattacharyya; Chandrav De; Anirban Mukherjee; Dwipayan Bhattacharya; Shantanu Santra; Rathindra N Sarkar; Dipanjan Banerjee; Shubhasish K Guha; Utpal K Datta; Sekhar Chakrabarti
Journal:  Virol J       Date:  2010-07-06       Impact factor: 4.099

3.  Trends in the prevalence and distribution of HTLV-1 and HTLV-2 infections in Spain.

Authors:  Ana Treviño; Antonio Aguilera; Estrella Caballero; Rafael Benito; Patricia Parra; Jose M Eiros; Araceli Hernandez; Enrique Calderón; Manuel Rodríguez; Alvaro Torres; Juan García; Jose Manuel Ramos; Lourdes Roc; Goitzane Marcaida; Carmen Rodríguez; Matilde Trigo; Cesar Gomez; Raul Ortíz de Lejarazu; Carmen de Mendoza; Vincent Soriano
Journal:  Virol J       Date:  2012-03-23       Impact factor: 4.099

4.  Association of Patients' Geographic Origins with Viral Hepatitis Co-infection Patterns, Spain.

Authors:  Santiago Pérez Cachafeiro; Ana María Caro-Murillo; Juan Berenguer; Ferran Segura; Felix Gutierrez; Francesc Vidal; Maria Angeles Martinez-Perez; Julio Sola; Roberto Muga; Santiago Moreno
Journal:  Emerg Infect Dis       Date:  2011-06       Impact factor: 6.883

Review 5.  Update on HIV/HCV coinfection.

Authors:  Vincent Soriano; Eugenia Vispo; Jose Vicente Fernandez-Montero; Pablo Labarga; Pablo Barreiro
Journal:  Curr HIV/AIDS Rep       Date:  2013-09       Impact factor: 5.495

6.  Incidence of hepatitis C virus (HCV) in a multicenter cohort of HIV-positive patients in Spain 2004-2011: increasing rates of HCV diagnosis but not of HCV seroconversions.

Authors:  Paz Sobrino-Vegas; Susana Monge Corella; Sergio Serrano-Villar; Félix Gutiérrez; José Ramón Blanco; Ignacio Santos; Jorge del Romero; Ferrán Segura; Joaquín Portilla; Santiago Moreno Guillén; Julia del Amo
Journal:  PLoS One       Date:  2014-12-30       Impact factor: 3.240

7.  Human Immunodeficiency Virus/Hepatits C Virus Coinfection in Spain: Elimination Is Feasible, but the Burden of Residual Cirrhosis Will Be Significant.

Authors:  Juan Berenguer; Inmaculada Jarrín; Leire Pérez-Latorre; Víctor Hontañón; María J Vivancos; Jordi Navarro; María J Téllez; Josep M Guardiola; José A Iribarren; Antonio Rivero-Juárez; Manuel Márquez; Arturo Artero; Luis Morano; Ignacio Santos; Javier Moreno; María C Fariñas; María J Galindo; María A Hernando; Marta Montero; Carmen Cifuentes; Pere Domingo; José Sanz; Lourdes Domíngez; Oscar L Ferrero; Belén De la Fuente; Carmen Rodríguez; Sergio Reus; José Hernández-Quero; Gabriel Gaspar; Laura Pérez-Martínez; Coral García; Lluis Force; Sergio Veloso; Juan E Losa; Josep Vilaró; Enrique Bernal; Sari Arponen; Amat J Ortí; Ángel Chocarro; Ramón Teira; Gerardo Alonso; Rafael Silvariño; Ana Vegas; Paloma Geijo; Josep Bisbe; Herminia Esteban; Juan González-García
Journal:  Open Forum Infect Dis       Date:  2018-01-12       Impact factor: 3.835

8.  Impact of universal access to hepatitis C therapy on HIV-infected patients: implementation of the Spanish national hepatitis C strategy.

Authors:  A Rivero-Juarez; L F Lopez-Cortes; M Castaño; D Merino; M Marquez; M Mancebo; F Cuenca-Lopez; P Jimenez-Aguilar; I Lopez-Montesinos; S Lopez-Cardenas; A Collado; M A Lopez-Ruz; M Omar; F Tellez; X Perez-Stachowski; J Hernandez-Quero; J A Girón-Gonzalez; E Fernandez-Fuertes; A Rivero
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-10-27       Impact factor: 3.267

9.  All-cause mortality in the cohorts of the Spanish AIDS Research Network (RIS) compared with the general population: 1997-2010.

Authors:  Victoria Hernando; Belen Alejos; Susana Monge; Juan Berenguer; Lourdes Anta; David Vinuesa; Rosario Palacios; Roberto Muga; Santiago Moreno; Inma Jarrin
Journal:  BMC Infect Dis       Date:  2013-08-20       Impact factor: 3.090

10.  Human Immunodeficiency Virus/Hepatitis C Virus Coinfection in Spain: Prevalence and Patient Characteristics.

Authors:  Juan Berenguer; Antonio Rivero; Inmaculada Jarrín; María J Núñez; María J Vivancos; Manel Crespo; María J Téllez; Pere Domingo; José A Iribarren; Arturo Artero; Manuel Márquez; Ignacio Santos; Javier Moreno; Marta Montero; Juan González-García
Journal:  Open Forum Infect Dis       Date:  2016-03-11       Impact factor: 3.835
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.